--- title: 'Associate Director, Rare Disease Product Marketing at REGENXBIO' canonical: 'https://feeny.ai/job/associate-director-rare-disease-product-marketing-regenxbio-rockville-r2p05phcvmx8' type: 'job' last_seen: '2026-09-14' --- # Associate Director, Rare Disease Product Marketing at REGENXBIO - **Company:** REGENXBIO - **Location:** Rockville, MD - **Employment:** full-time - **Work type:** hybrid - **Posted:** 2026-08-14 - **Last confirmed live:** 2026-09-14 - **Apply:** https://jobs.lever.co/regenxbio/5d6bde28-58b0-4b00-a6f5-abc26384b180 ## Job description ## Who we are REGENXBIO is an exceptional place to work. You'll have the opportunity to collaborate with some of the best and the brightest people, touch amazing science, and be a part of extraordinary plans. Our core values: Trust, Accountability, Perseverance, and Innovation drive everything we do. We aim to bring these values to life every day with all that we do, and we believe that what we do matters - to patients, to their families, and to their communities. ## What you'll be doing - Lead the development and execution of integrated rare disease brand plans, including customer segmentation, positioning, messaging, and omnichannel tactics for HCP, payer, caregiver, and field audiences. - Translate market research, competitive intelligence, and field feedback into actionable recommendations that inform brand planning, launch readiness, value positioning, and marketing performance. - Develop and manage HCP- and payer-facing promotional materials, including digital and field-facing tools, through the promotional review process to ensure strategic alignment, scientific accuracy, and timely execution. - Manage agency and vendor partnerships for market research, creative development, media, analytics, and other marketing services to ensure high-quality, actionable deliverables on time and within budget. - Lead annual operating planning and marketing budget management; prioritize initiatives, track spend and coordinate promotional asset lifecycle updates to support evolving brand and launch needs. - Collaborate with Commercial, Medical, Market Access, Regulatory/Legal review, R&D, Corporate Affairs, and field teams to align brand strategy, customer engagement, advisory boards, peer-to-peer education, and congress initiatives. - Communicate clear, actionable recommendations tailored to senior stakeholders; partner with commercial training and field teams to enable effective rollout and adoption of new materials and initiatives. - Travel up to 25% for medical congresses, conferences, and internal meetings. - It is imperative that REGENXBIO employees embody our core values by working collaboratively, building strong relationships and using clear communication to meet shared objectives. ## What we're looking for We set our employees up for success.  To be successful in this role and help us achieve our goals, we are looking for someone with the following skills and qualifications: - Bachelor's degree required; advanced degree (MS, PhD, MBA, PharmD) in life sciences, business, or a healthcare-related field preferred. - 7+ years of product marketing, brand management, marketing strategy, commercial insights, or related commercial experience within biotech or pharmaceutical industry, with rare disease and/or Duchenne experience preferred. - Proven experience supporting or leading product launch preparation and lifecycle activities, including customer segmentation, brand strategy, promotional material development and approval, and field enablement. - Strong understanding of drug development and commercialization processes, ideally within a rare disease, specialty, or gene therapy setting. - Demonstrated ability to integrate primary (qualitative and quantitative) and secondary research into clear strategic recommendations, value propositions, and marketing tactics. - Experience developing HCP-, caregiver- payer-facing content and working through promotional review and approval processes while maintaining scientific accuracy and compliance. - Excellent written and verbal communication skills with the ability to influence and engage stakeholders across all levels of the organization. - Track record of cross-functional collaboration with marketing, medical, market access, regulatory/legal, commercial operations, and field teams. - Highly organized self-starter with strong analytical and problem-solving skills and comfort operating in ambiguity. - Proficient with Excel, PowerPoint, and relevant market research, customer, and analytics tools; able to turn data into clear marketing implications. - Experience managing agencies, vendors, and external partners to deliver high-quality marketing and insights work on time and within budget; rare disease experience strongly preferred. Why should you apply? By joining REGENXBIO, you will have the opportunity to be a part of a growing company, with an incredible team, who is passionate about developing novel AAV gene therapies for patients in need. We offer a comprehensive and competitive benefit & compensation package which includes market-competitive salaries, an annual bonus program, education assistance, retirement plan with employer match, stock options at all levels, summer hours and more! The estimated compensation range for this role is $160,000 to $215,000 annually. The actual salary offered to the final candidate depends on a number of factors such as relevant work experience, skills, education, and years of experience. In addition, professional development is important to us.  By joining our team, you’ll have the opportunity to be exposed to challenging projects and have access to development resources to help you grow personally and professionally. ## About REGENXBIO ## Company Overview - **One-liner**: REGENXBIO is a clinical-stage biotechnology company developing one-time gene therapies for rare and retinal diseases using its proprietary AAV vector platform. - **Entity Type**: Public (NASDAQ: RGNX) - **Headquarters**: Rockville, Maryland, United States - **Founded**: 2008 (founded as a company; operations began in 2009) - **Founders**: Not publicly listed as individual founders; the company was spun out from the gene therapy research of the University of Pennsylvania and licensed its NAV Technology Platform from the university. ## Core Business - **Primary industry**: Biotechnology – Gene Therapy (AAV-based) - **Target customers**: B2B (pharma partners like AbbVie, Nippon Shinyaku) and B2G (regulatory agencies, clinical trial sites); ultimate customers are patients with rare and retinal diseases (Duchenne muscular dystrophy, MPS I, MPS II, wet AMD, diabetic retinopathy). - **Mission or purpose statement**: “To improve lives through the curative potential of gene therapy.” [regenxbio.com](https://www.regenxbio.com/culture-careers/) ## Products & Services - **NAV® Technology Platform**: Proprietary AAV vector gene delivery platform (including AAV8 and AAV9) used for internal programs and licensed to partners (e.g., Novartis for ZOLGENSMA®). - **ABBV-RGX-314** (in collaboration with AbbVie): Investigational one-time gene therapy for wet age-related macular degeneration (wet AMD) and diabetic retinopathy (DR). In pivotal clinical trials. - **RGX-202** (Duchenne muscular dystrophy): Phase I/II/III AFFINITY DUCHENNE® trial; pivotal phase expected to support BLA submission in 2026 using accelerated approval pathway. [ir.regenxbio.com](https://ir.regenxbio.com/static-files/92731f97-50e3-4285-b793-d2cdc99611aa) - **RGX-121** (MPS II – Hunter syndrome): In partnership with Nippon Shinyaku; late-stage development. - **RGX-111** (MPS I – Hurler syndrome): In partnership with Nippon Shinyaku; clinical development. - **Manufacturing**: In-house cGMP production facility (REGENXBIO Manufacturing Innovation Center – RMIC) in Rockville, MD, operational since mid-2022. ## Market Standing - **Valuation/Market Cap**: $447.8 million (as of recent data). [linkedin.com](https://linkedin.com/company/regenx) - **Key Metric**: Annual Revenue $170.4 million (primarily from license and collaboration revenue). [linkedin.com](https://linkedin.com/company/regenx) - **Notable Investors/Partners**: - AbbVie (collaboration for ABBV-RGX-314) - Nippon Shinyaku (partnerships for RGX-121 and RGX-111) - Novartis (licensee for ZOLGENSMA® using NAV vectors) - **Growth Signals**: - Headcount: 296 employees (+1.3% YoY). [linkedin.com](https://linkedin.com/company/regenx) - BLA submission for RGX-202 targeted for 2026. - RMIC facility operational since 2022, enabling scalable clinical and commercial manufacturing. - Scholarly output: 160 works, 7,337 citations, field-weighted citation impact of 2.6 (highly influential). [linkedin.com](https://linkedin.com/company/regenx) ## Competitive Advantages - **Proprietary NAV Technology Platform**: Exclusive rights to a large portfolio of AAV vectors (including AAV8 and AAV9), the foundation for multiple approved and investigational gene therapies. [ir.regenxbio.com](https://ir.regenxbio.com/static-files/92731f97-50e3-4285-b793-d2cdc99611aa) - **End-to-end capabilities**: Integrated in-house R&D, preclinical development, clinical development, and cGMP manufacturing. - **Proven platform**: Thousands of patients have been treated with AAV vectors from the NAV platform (including via Novartis’ ZOLGENSMA®). - **Late-stage pipeline**: Multiple programs in pivotal or near-pivotal trials (RGX-202, ABBV-RGX-314) with clear regulatory pathways. ## Strategic Focus - **Near-term**: Advance RGX-202 toward BLA submission in 2026; continue pivotal trials for ABBV-RGX-314 in wet AMD and diabetic retinopathy. - **Long-term**: Expand pipeline in retinal, neuromuscular, and neurodegenerative diseases; leverage RMIC for commercial-scale manufacturing; deepen partnerships with AbbVie and Nippon Shinyaku. - **Platform expansion**: Ongoing research to expand NAV vector capabilities and develop new AAV-based therapies. ## Why Work Here - **Mission-driven culture**: “Patient-focused, driven by results, fosters collaboration.” Core values emphasize accountability, innovation, and serving patients with limited therapeutic options. [regenxbio.com](https://www.regenxbio.com/culture-careers/) - **Impactful work**: Opportunity to work on one-time gene therapies that could fundamentally alter the course of devastating diseases. - **Growth & stability**: Public company with late-stage pipeline, strong partnerships, and a clear path to commercialization. - **Location & facilities**: Headquarters in Rockville, MD, with a state-of-the-art cGMP manufacturing facility (RMIC) on site. - **Work policy**: Not explicitly stated as remote/hybrid; positions appear to be on-site (based on job listings in Rockville and field-based Medical Science Liaison roles). - **Perks**: Comprehensive and competitive benefits for employees and families. [regenxbio.com](https://www.regenxbio.com/culture-careers/) - **Engineering & science culture**: High scholarly output and citation impact; emphasis on cross-functional collaboration between research, manufacturing, and clinical teams. - **Recruitment note**: REGENXBIO warns of fraudulent job offers; all applications go through their official Lever portal. [regenxbio.com](https://www.regenxbio.com/culture-careers/) ## Sources 1. [regenxbio.com – Culture & Careers](https://www.regenxbio.com/culture-careers/) 2. [linkedin.com – REGENXBIO company page](https://linkedin.com/company/regenx) 3. [ir.regenxbio.com – 10-K Filing (Business Overview)](https://ir.regenxbio.com/static-files/92731f97-50e3-4285-b793-d2cdc99611aa) 4. [ir.regenxbio.com – Investor Overview](https://ir.regenxbio.com/investor-overview) 5. [jobs.lever.co – REGENXBIO careers](https://jobs.lever.co/regenxbio) ## Other roles at REGENXBIO - [Associate Director, People Business Partner](https://feeny.ai/job/associate-director-people-business-partner-regenxbio-rockville-fmx3gbzx681y) — Rockville, MD - [Director, Commercial Data, Advanced Analytics & Forecasting](https://feeny.ai/job/director-commercial-data-advanced-analytics-forecasting-regenxbio-remote-88y6fvc5kv5j) - [Market Development Director - Southeast Region](https://feeny.ai/job/market-development-director-southeast-region-regenxbio-remote-b1hhp987p5v1) - [Associate Director, Data & Information Architecture](https://feeny.ai/job/associate-director-data-information-architecture-regenxbio-rockville-b0m5vrmrm33p) — Rockville, MD - [Senior Medical Science Liaison - DMD/Neuromuscular (South)](https://feeny.ai/job/senior-medical-science-liaison-dmd-neuromuscular-south-regenxbio-remote-4qggqdykm9ym) - [Senior Medical Science Liaison - DMD/Neuromuscular (Northeast)](https://feeny.ai/job/senior-medical-science-liaison-dmd-neuromuscular-northeast-regenxbio-remote-47qpcgnnyhpc) - [Senior Medical Science Liaison - DMD/Neuromuscular (West Coast)](https://feeny.ai/job/senior-medical-science-liaison-dmd-neuromuscular-west-coast-regenxbio-west-coast-yerem2kwy7ca) — West Coast - [Senior Director, Global Program Development Lead - DMD/Neuromuscular](https://feeny.ai/job/senior-director-global-program-development-lead-dmd-neuromuscular-regenxbio-xbereeg0zrc8) — Rockville, MD - [Senior Director/Director, Medical Science Liaisons (Neuromuscular/DMD)](https://feeny.ai/job/senior-director-director-medical-science-liaisons-neuromuscular-dmd-regenxbio-aeca83gb75e2)